Showing 1,921 - 1,940 results of 101,436 for search '(( 5 ((c decrease) OR (a decrease)) ) OR ( 5 ((nm decrease) OR (nn decrease)) ))', query time: 1.49s Refine Results
  1. 1921

    PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

    Published 2016
    “…<p><b><i>Background:</i></b> Persistent hyperkalemia (serum potassium (K) ≥5.5 mEq/l) is a common condition in hemodialysis (HD) patients, is associated with increased mortality, and treatment options are limited. …”
  2. 1922
  3. 1923

    rAd-p53 induces apoptosis in HCC cell lines with increased Fbxw7 and decreased c-Myc and Cyclin E. by Kangsheng Tu (428934)

    Published 2013
    “…Quantification of RT-PCR for p53 and Fbxw7 indicated elevated mRNA levels for rAd-p53 infected Hep3B cells, whereas c-Myc and Cyclin E levels were not significantly decreased. …”
  4. 1924

    TNFα significantly decreases PRLR immunoreactivity in the outer root sheath of hair follicles. by Ewan A. Langan (405804)

    Published 2013
    “…<p>(A) PRLR IR in the outer root sheath of control hair follicles (black arrows) was reduced in comparison PRLR IR after treatment with TNFα at concentrations of (B) 0.5 ng/ml and (C) 5 ng/ml. …”
  5. 1925
  6. 1926

    DataSheet_1_Failure to decrease HbA1c levels following TB treatment is associated with elevated Th1/Th17 CD4+ responses.pdf by Robert Krause (504842)

    Published 2023
    “…Participants were stratified based on stable/increased HbA1c (n = 16) versus decreased HbA1c (n = 46) levels from treatment initiation to 12 month follow-up.…”
  7. 1927
  8. 1928
  9. 1929
  10. 1930
  11. 1931
  12. 1932
  13. 1933
  14. 1934
  15. 1935
  16. 1936

    Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis by Zhixia Li (2736331)

    Published 2016
    “…Dulaglutide, exenatide long-acting release (exe_lar), liraglutide and taspoglutide had significant lowering effect when compared with sitagliptin (HbA1c<7.0%) and insulin (HbA1c<6.5%). Finally, according to SUCRAs, placebo, thiazolidinediones and albiglutide had the best decrease effect on hypoglycemia; sulphanylureas, sitagliptin and insulin decrease the incidence of treatment discontinuation most; exe_lar and dulaglutide had the highest impact on glycemic level among 13 treatments.…”
  17. 1937
  18. 1938
  19. 1939
  20. 1940